Incyte
North America, Delaware, United States, Wilmington
Description
Incyte is a drug discovery and development company which hopes to build a proprietary product pipeline of novel small molecule drugs.
Investor Profile
Incyte has backed more than 5 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 20% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series B, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom.
- Strong thematic focus on Medical, Biotechnology, Life Science.
Stage Focus
- Seed (20%)
- Series B (20%)
- Series Unknown (20%)
- Post Ipo Equity (20%)
- Corporate Round (20%)
Country Focus
- United States (80%)
- United Kingdom (20%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Industry Focus
- Medical
- Biotechnology
- Life Science
- Health Care
- Therapeutics
- E-learning
- Information Technology
- Pharmaceutical
- Medical Device
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
